Ardent Health (ARDT) Projected to Post Quarterly Earnings on Tuesday

Ardent Health (NYSE:ARDT) will likely be issuing its Q1 2026 results after the market closes on Tuesday, May 5th. Analysts expect the company to announce earnings of $0.18 per share and revenue of $1.5778 billion for the quarter. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. Parties may visit the the company’s upcoming Q1 2026 earning results page for the latest details on the call scheduled for Wednesday, May 6, 2026 at 10:00 AM ET.

Ardent Health (NYSE:ARDT) last released its quarterly earnings results on Wednesday, March 4th. The company reported $0.32 earnings per share for the quarter, missing the consensus estimate of $0.35 by ($0.03). Ardent Health had a net margin of 2.15% and a return on equity of 14.30%. The business had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.63 billion. On average, analysts expect Ardent Health to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Ardent Health Stock Performance

NYSE:ARDT opened at $10.13 on Friday. The business’s 50-day moving average price is $9.25 and its two-hundred day moving average price is $9.88. Ardent Health has a twelve month low of $8.07 and a twelve month high of $15.48. The stock has a market cap of $1.45 billion, a P/E ratio of 10.56 and a beta of 0.93. The company has a quick ratio of 1.85, a current ratio of 1.97 and a debt-to-equity ratio of 0.64.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. JPMorgan Chase & Co. lowered their price target on Ardent Health from $12.00 to $11.00 and set a “neutral” rating on the stock in a report on Tuesday, January 20th. Royal Bank Of Canada lowered their price target on Ardent Health from $14.00 to $13.00 and set an “outperform” rating on the stock in a report on Monday, March 9th. Leerink Partners lowered their price target on Ardent Health from $16.00 to $15.00 and set an “outperform” rating on the stock in a report on Friday, March 6th. Finally, Zacks Research raised Ardent Health from a “strong sell” rating to a “hold” rating in a report on Wednesday, March 25th. Seven research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $14.25.

Hedge Funds Weigh In On Ardent Health

A number of large investors have recently modified their holdings of ARDT. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Ardent Health by 103.8% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,104 shares of the company’s stock valued at $194,000 after buying an additional 7,182 shares in the last quarter. Goldman Sachs Group Inc. raised its holdings in shares of Ardent Health by 1,684.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock valued at $10,558,000 after buying an additional 724,841 shares in the last quarter. Jane Street Group LLC raised its holdings in shares of Ardent Health by 235.1% during the 1st quarter. Jane Street Group LLC now owns 57,468 shares of the company’s stock valued at $790,000 after buying an additional 40,318 shares in the last quarter. Acadian Asset Management LLC raised its holdings in shares of Ardent Health by 574.9% during the 1st quarter. Acadian Asset Management LLC now owns 40,238 shares of the company’s stock valued at $550,000 after buying an additional 34,276 shares in the last quarter. Finally, Geode Capital Management LLC raised its holdings in shares of Ardent Health by 0.6% during the 2nd quarter. Geode Capital Management LLC now owns 286,848 shares of the company’s stock valued at $3,918,000 after buying an additional 1,769 shares in the last quarter.

About Ardent Health

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.